Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

Registers› Irish medicines ›Denosumab

Medicines register · Ireland

Denosumab — medicines in Ireland

33 authorised products containing Denosumab, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,295 authorised products are in this register. Synced 06 Oct 2026, 03:23 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Acvybra 60 mg solution for injection in pre-filled syringe EU/1/25/1983/001

Denosumab

Reddy Holding GmbH

—

Bildyos 60 mg solution for injection EU/1/25/1978/002

Denosumab

Sciencepharma Sp. z o.o.

—

Bildyos 60 mg solution for injection in pre-filled syringe EU/1/25/1978/001

Denosumab

Sciencepharma Sp. z o.o.

—

Bilprevda 120 mg solution for injection EU/1/25/1979/001

Denosumab

Henlius Europe GmbH

—

BOMYNTRA 120 mg solution for injection in pre-filled syringe EU/1/25/1953/04-06

Denosumab

Fresenius Kabi Deutschland GmbH

—

BOMYNTRA 120 mg solution for injection in vial EU/1/25/1953/01-03

Denosumab

Fresenius Kabi Deutschland GmbH

—

Conexxence 60 mg solution for injection in pre-filled syringe EU/1/25/1954/01

Denosumab

Fresenius Kabi Deutschland GmbH

—

Degevma 120 mg solution for injection EU/1/25/1985/001-002

Denosumab

—

Denbrayce 120 mg solution for injection EU/1/25/1936/001

Denosumab

Mabxience Research, S.L.

—

Enwylma 120 mg solution for injection EU/1/25/1944/001

Denosumab

—

Evfraxy 60 mg solution for injection in pre-filled syringe EU/1/25/1946/001

Denosumab

Biosimilar Collaborations Ireland Limited

—

Izamby 60 mg solution for injection in pre-filled syringe EU/1/25/1935/001

Denosumab

Mabxience Research, S.L.

—

Jubbonti 60 mg solution for injection in pre-filled syringe EU/1/24/1813/001

Denosumab

—

Jubereq 120 mg solution for injection EU/1/25/1921/001-003

Denosumab

Accord Healthcare S.L.U.

—

Junod 60 mg solution for injection in pre-filled syringe EU/1/25/1933/001

Denosumab

Gedeon Richter Plc

—

Kefdensis 60 mg solution for injection in pre-filled syringe EU/1/25/1980/001

Denosumab

Stada Arzneimittel AG

—

Obodence 60 mg solution for injection in pre-filled syringe EU/1/24/1890/001

Denosumab

Samsung Bioepis NL B.V.

—

Osenvelt 120 mg solution for injection EU/1/24/1904/001-003

Denosumab

Celltrion Healthcare Hungary Kft.

—

Osqay 60 mg solution for injection in pre-filled syringe EU/1/25/1997/001

Denosumab

Theramex Ireland Limited

—

Osvyrti 60mg Solution for injection in pre-filled syringe EU/1/25/1922/002

Denosumab

Accord Healthcare S.L.U.

—

Ponlimsi 60 mg solution for injection in pre-filled syringe EU/1/25/1986/001

Denosumab

—

Prolia 60 mg solution for injection in pre-filled syringe EU/1/10/618/1-4

Denosumab

Amgen Europe B.V.,

—

Rolcya 60 mg solution for injection in pre-filled syringe EU/1/25/1958/001

Denosumab

—

Stoboclo 60 mg solution for injection in pre-filled syringe EU/1/24/1905/001

Denosumab

Celltrion Healthcare Hungary Kft.

—

Vevzuo 120 mg solution for injection EU/1/25/1945/001-003

Denosumab

Biosimilar Collaborations Ireland Limited

—

Vysribli (previously known as Denosumab Intas) 60 mg solution for injection in pre-filled syringe EU/1/25/1993/001

Denosumab

Intas Third Party Sales 2005 S.L.

—

Wyost 120 mg solution for injection EU/1/24/1812/001

Denosumab

—

Xbonzy 120 mg solution for injection EU/1/25/1982/001-004

Denosumab

Reddy Holding GmbH

—

Xbryk 120 mg solution for injection EU/1/24/1889/001-002

Denosumab

Samsung Bioepis NL B.V.

—

XGEVA 120 mg solution for injection EU/1/11/703/001-002

Denosumab

Amgen Europe B.V.,

—

Yaxwer 120 mg solution for injection EU/1/25/1934/001-003

Denosumab

Gedeon Richter Plc

—

ZADENVI 60 mg solution for injection in pre-filled syringe EU/1/25/1937/001

Denosumab

—

Zvogra 120 mg solution for injection EU/1/25/1981/001-003

Denosumab

Stada Arzneimittel AG

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 6 October 2026. https://priyalifescience.com/medicines/substance/denosumab

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.